Glycanostics Logo
THE COMPANY
Glycanostics is an innovative startup focused on revolutionizing cancer diagnostics, particularly for prostate cancer. Their magnetic beads-based ELISA test detects glycan changes with high accuracy. The company aims to bring its groundbreaking diagnostics to the US and EU markets. Glycanostics has received prestigious grants and awards, including from the European Research Council (ERC) and the EIC Accelerator program.